Repeat Prostate Biopsy and the Incremental Risk of Clinically Insignificant Prostate Cancer
Matthew J. Resnick(Vanderbilt University Medical Center), Thomas J. Guzzo(Hospital of the University of Pennsylvania), Alan J. Wein(University of Miami), Laurie Magerfleisch(Hospital of the University of Pennsylvania), Daniel J. Lee(University of Pennsylvania), John E. Tomaszewski(University of Pennsylvania), Keith VanArsdalen(University of Pennsylvania), S. Bruce Malkowicz(Hospital of the University of Pennsylvania)
Cited by 41
Related Papers
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459
Renal Carcinomas With the t(6;11)(p21;q12)
|The American Journal of Surgical Pathology|2005|291